2024 BBMESS Research Day








Interested in participating?
Please fill the forms below
-
Abstract submission deadline: May 24, 2024 at 11:59 EST
https://forms.gle/TNLVLxDVmvk8JjcA9
-
Registration
https://forms.gle/RTFBqyhMR8p17UGd7
* We have completed the refund for those who have paid the registration fee. Contact us if you have any questions!
Download the PDF version:
Key Speaker:

​
Adams Hendricks
Adams Hendricks is an Associate Professor in the Department of Bioengineering at McGill University.
He completed his Master's studies at Virginia Polytechnic Institute and State University and Ph.D. at University of Michigan. His research focuses on the two motor proteins, kinesin and cytoplasmic dynein, and their role in many neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer’s disease, and Huntington’s disease. He is also interested in how motor proteins function collectively, and how interactions among motor proteins and with the complex cellular environment modulate their behavior. He aims to develop methods to extend the application of single molecule techniques such as optical trapping, FRET, and subpixel resolution tracking to examine motor function in living cells.
​

David Juncker
David Juncker is the Chair of the Department of Bioengineering at McGill University.
​
He is exploring various facets of miniaturization and integration in biology and medicine, which includes the conception, engineering and utilization of novel micro and nanotechnologies for manipulating, stimulating and studying oligonucleotides, proteins, cells, and tissues. His research foci comprise the development of novel scalable antibody microarrays for protein profiling and their use for biomarker discovery and early diagnosis of disease such as cancer; self-powered lab-on-a-chip for diagnostics at the point-of-care and low-cost thread-based devices for use in global health applications; microfluidic probes for brain slice perfusion and single cell manipulation; and nanogradients for studying neuronal cell navigation.
​

Warren Chan
Warren Chan is a Professor in the Institute of Biomedical Engineering at the University of Toronto. He is also a Canada Research Chair in Nanobioengineering & Director
​
He focuses on studying and understanding the proteomic and genomic changes associated with abnormal cells (e.g., cancer cells or virally infected cells) and tissues. His team aims to elucidate the cell’s molecular dynamics by using recent developments in nanotechnology (e.g., inorganic nanostructures), microtechnology (e.g., micro-electromechanical systems and capillary flow systems), and molecular engineering (e.g., phage-display) as well as engineering new instrumentation and techniques to address biological questions. A fundamental understanding of molecular processes with technology developments should lead to the design of novel diagnostic schemes and therapeutic strategies.
​
Sponsors and Contributors





